Market Forecast by Countries (Germany, United Kingdom, France, Italy, Russia, Spain, Rest of Europe), By Product (Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, Recombinant Vaccines), By Animal Type (Livestock, Companion), By Route of Administration (Subcutaneous, Intramuscular, Intranasal) And Competitive Landscape
Product Code: ETC397310 | Publication Date: Jun 2023 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 250 | No. of Figures: 50 | No. of Tables: 25 | |
According to 6Wresearch internal database and industry insights, the Europe Animal Vaccines Market is projected to grow at a Compound Annual Growth Rate of 8.9% from 2025 to 2031. Europe Animal Vaccines Market was valued at approximately USD 3.35 billion. in 2024 and is expected to reach around USD 5.60 billion by 2031.
Report Name | Europe Animal Vaccines Market |
Forecast Period | 2025-2031 |
CAGR | 8.9% |
Market Size | USD 5.60 billion by 2031 |
Growing Sector | Animal Healthcare and Veterinary Pharmaceuticals |
The Europe Animal Vaccines Market report thoroughly covers the market by countries, by product, by animal type and by route of administration. The market report provides an unbiased and detailed analysis of the ongoing market trends, opportunities/high growth areas, and market drivers which would help the stakeholders to devise and align their market strategies according to the current and future market dynamics.
The Europe Animal Vaccines Market highly favourable growth will be due to an increase in the prevalence of zoonotic diseases, an increasing demand of animal-derived food products, and growing awareness of animal health. Other factors fuelling this growth include advancements in biotechnology and development in novel types of vaccines. The continuing prominence of livestock productivity and health keeps this market well-positioned for solid growth throughout Europe.
Europe Animal Vaccines Market is expected to grow at a significant CAGR of 8.9% during the forecast period 2025-2031. The Europe Animal Vaccines Market is experiencing growth due to multiple driving forces. As livestock farming continues to grow in Europe, there is an increase in demand for vaccines to help ensure animal welfare and limit infectious disease outbreaks. Second, Europe Animal Vaccines Market Growth is being further supported by increasing awareness of the benefits of vaccination among both farmers and pet owners, which enhances adoption rates. Along with these factors, government efforts and regulations aimed at controlling zoonotic diseases are a significant driving force in supporting overall market expansion.
The Europe Animal Vaccines Market faces several challenges which could hinder its growth, including regulatory complexities and the high cost of vaccine development. Issues related to vaccine stability during storage and distribution are also significant concerns, particularly in regions with inadequate cold chain infrastructure. Furthermore, the limited availability of trained professionals for vaccine administration and growing scepticism around vaccination among animal owners add to the challenges faced by the industry.
Trends in the Europe Animal Vaccines Industry include the increasing adoption of DNA and recombinant vaccines, which are more accurate and effective types of disease preventative solutions. Another key trend is the integration of technology in the form of smart vaccine delivery systems to increase immunization coverage rates. The rise of new types and combinations of vaccines has also been boosted by supporting research and development activities by key players in the industry who are increasing focus in this area.
The Europe Animal Vaccines Market offers unique opportunities to invest in the development of better vaccines for easily spread infectious diseases. Increased funding for veterinary research and investments in biotechnology provide opportunities for investment returns. Moreover, expanding animal farming practices and rising consumer demand for high-quality animal products will allow strategic investment opportunities in vaccine production and distribution networks for an expanding market..
There are various government regulations which contribute towards the Europe Animal Vaccines Market as there are strict regulations on vaccine approval, production, and distribution. Regulatory bodies, such as the European Medicines Agency (EMA), are responsible for maintaining and ensuring the quality, safety, and effectiveness of animal vaccines. Policies encouraging sustainable livestock farming practices, as well as regulations about disease prevention programs, have helped grow the market for these vaccines, encouraging a climate for them on the continent.
The future of the Europe Animal Vaccines Market appears highly promising, with anticipated advancements in vaccine technologies such as mRNA-based formulations. Advanced focus on One-Health approaches, which integrate animal and human health, is expected to drive further innovations. Moreover, Europe Animal Vaccines Market Share is likely to expand due to the surge in demand for personalized medicine and precision farming, fostering the development of tailored vaccine solutions and reinforcing the market’s growth well beyond 2031.
The report offers a comprehensive study of the subsequent market segments and their leading categories.
According to Ritika Kalra, Senior Research Analyst at 6Wresearch, Germany dominates the Europe Animal Vaccines Market due to its advanced livestock farming infrastructure, high adoption of veterinary healthcare practices, and strong government support for disease prevention programs. The country’s focus on animal welfare and biosecurity measures further strengthens its leading position in the market.
Attenuated Live Vaccines lead the market, driven by their strong efficacy in providing long-lasting immunity. These vaccines are widely preferred for both livestock and companion animals due to their ability to induce robust immune responses with fewer doses.
Livestock is the largest segment, fueled by the increasing demand for meat, dairy, and other animal products across Europe. Rising awareness of animal health and stringent regulations for disease prevention contribute to the higher adoption of vaccines in livestock populations.
Subcutaneous administration dominates the market, as it is widely used for its safety, effectiveness, and ease of administration in both large-scale livestock and companion animal vaccination programs. This route ensures proper immune response while minimizing stress for the animals.
The market report provides a detailed analysis of the following market segments:
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Europe Animal Vaccines Market Overview |
3.1 Europe Regional Macro Economic Indicators |
3.2 Europe Animal Vaccines Market Revenues & Volume, 2021 & 2031F |
3.3 Europe Animal Vaccines Market - Industry Life Cycle |
3.4 Europe Animal Vaccines Market - Porter's Five Forces |
3.5 Europe Animal Vaccines Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 Europe Animal Vaccines Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.7 Europe Animal Vaccines Market Revenues & Volume Share, By Animal Type, 2021 & 2031F |
3.8 Europe Animal Vaccines Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
4 Europe Animal Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Europe Animal Vaccines Market Trends |
6 Europe Animal Vaccines Market, 2021 & 2031F |
6.1 Europe Animal Vaccines Market, Revenues & Volume, By Product, 2021 & 2031F |
6.2 Europe Animal Vaccines Market, Revenues & Volume, By Animal Type, 2021 & 2031F |
6.3 Europe Animal Vaccines Market, Revenues & Volume, By Route of Administration, 2021 & 2031F |
7 Germany Animal Vaccines Market, 2021 & 2031F |
7.1 Germany Animal Vaccines Market, Revenues & Volume, By Product, 2021 & 2031F |
7.2 Germany Animal Vaccines Market, Revenues & Volume, By Animal Type, 2021 & 2031F |
7.3 Germany Animal Vaccines Market, Revenues & Volume, By Route of Administration, 2021 & 2031F |
8 United Kingdom Animal Vaccines Market, 2021 & 2031F |
8.1 United Kingdom Animal Vaccines Market, Revenues & Volume, By Product, 2021 & 2031F |
8.2 United Kingdom Animal Vaccines Market, Revenues & Volume, By Animal Type, 2021 & 2031F |
8.3 United Kingdom Animal Vaccines Market, Revenues & Volume, By Route of Administration, 2021 & 2031F |
9 France Animal Vaccines Market, 2021 & 2031F |
9.1 France Animal Vaccines Market, Revenues & Volume, By Product, 2021 & 2031F |
9.2 France Animal Vaccines Market, Revenues & Volume, By Animal Type, 2021 & 2031F |
9.3 France Animal Vaccines Market, Revenues & Volume, By Route of Administration, 2021 & 2031F |
10 Italy Animal Vaccines Market, 2021 & 2031F |
10.1 Italy Animal Vaccines Market, Revenues & Volume, By Product, 2021 & 2031F |
10.2 Italy Animal Vaccines Market, Revenues & Volume, By Animal Type, 2021 & 2031F |
10.3 Italy Animal Vaccines Market, Revenues & Volume, By Route of Administration, 2021 & 2031F |
11 Russia Animal Vaccines Market, 2021 & 2031F |
11.1 Russia Animal Vaccines Market, Revenues & Volume, By Product, 2021 & 2031F |
11.2 Russia Animal Vaccines Market, Revenues & Volume, By Animal Type, 2021 & 2031F |
11.3 Russia Animal Vaccines Market, Revenues & Volume, By Route of Administration, 2021 & 2031F |
12 Spain Animal Vaccines Market, 2021 & 2031F |
12.1 Spain Animal Vaccines Market, Revenues & Volume, By Product, 2021 & 2031F |
12.2 Spain Animal Vaccines Market, Revenues & Volume, By Animal Type, 2021 & 2031F |
12.3 Spain Animal Vaccines Market, Revenues & Volume, By Route of Administration, 2021 & 2031F |
13 Rest of Europe Animal Vaccines Market, 2021 & 2031F |
13.1 Rest of Europe Animal Vaccines Market, Revenues & Volume, By Product, 2021 & 2031F |
13.2 Rest of Europe Animal Vaccines Market, Revenues & Volume, By Animal Type, 2021 & 2031F |
13.3 Rest of Europe Animal Vaccines Market, Revenues & Volume, By Route of Administration, 2021 & 2031F |
14 Europe Animal Vaccines Market Key Performance Indicators |
15 Europe Animal Vaccines Market - Opportunity Assessment |
15.1 Europe Animal Vaccines Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Europe Animal Vaccines Market Opportunity Assessment, By Product, 2021 & 2031F |
15.3 Europe Animal Vaccines Market Opportunity Assessment, By Animal Type, 2021 & 2031F |
15.4 Europe Animal Vaccines Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
16 Europe Animal Vaccines Market - Competitive Landscape |
16.1 Europe Animal Vaccines Market Revenue Share, By Companies, 2024 |
16.2 Europe Animal Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Company Profiles |
18 Recommendations |
19 Disclaimer |